Press Releases

GUANGZHOU, China, Sept. 10, 2019 /PRNewswire/ -- SEED AWARD, launched by Seedland Group, held its European Semifinal on September 5, 2019, in London, where ten teams competed for three entries to the Global Final.

LOMBARD, Ill., Sept. 10, 2019 /PRNewswire/ -- Advantage Living Centers, which operates short and long-term rehabilitation and skilled nursing centers and assisted living center

UPPSALA, Sweden, Sept. 10, 2019 /PRNewswire/ -- Beactica Therapeutics, the Swedish drug discovery company, today announced the appointment of a Head of Preclinical Development, two new members of the Board, and a clinical advisor. The appointments are made to strengthen the organisation as the company sharpens its strategic focus on drug discovery and development. 

New Sterile Transperineal Needle Guide enables the ExactVu™ micro-ultrasound system to be used across Europe and in clinical settings requiring Transperineal access TORONTO, Sept. 10, 2019 /PRNewswire/ - Exact Imaging (

TOKYO, MUNICH, and BASKING RIDGE, N.J., Sept. 10, 2019 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced the presentation of updated phase 1 data for U3-1402, an investigational HER3 targeting antibody drug conjugate (ADC), in 30 patients with metastatic EGFR mutat

TOKYO, MUNICH, and BASKING RIDGE, N.J., Sept. 10, 2019 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced the presentation of updated phase 1 clinical results and new biomarker data for DS-1062, an investigational TROP2 targeting antibody drug conjugat

BERKELEY, Calif., Sept. 10, 2019 /PRNewswire/ -- Today, the U.S. Patent and Trademark Office (USPTO) granted a new CRISPR-Cas9 patent to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering single-molecule guide RNA

WASHINGTON, Sept. 10, 2019 /PRNewswire/ -- U.S. News & World Report, the global authority in health care rankings and consumer advice, today announced a new collaboration with

CALGARY, Sept. 9, 2019 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW) announces that, pursuant to the terms and conditions of its stock option plan, it has granted an aggregate of 1,118,000 stock options ("Options") to purchase common shares ("Common Shares") of Willow to certain employees. The Options exp

BIRMINGHAM, Ala., Sept. 9, 2019 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced the pricing of its underwritten public offering of $500 million in aggregate principal amount of its 4.500% senior notes due 2028 at a public offering price of 100% of the principal amount and $500 million in aggregat